[Ip-health] Feb 19: Achieving Innovation + Access in Global Pharmaceutical Markets

[Mike Palmedo]

A few changes have been made since my first message about this event
last Friday:
------------------------------------------------------------------------------------

Achieving Innovation + Access in Global Pharmaceutical Markets

A Discussion with Professor John Barton
Stanford University School of Law

With Responses by
Joseph Damond, Pfizer
ME Senator Sharon Treat, National Legislative Association on
Prescription Drug Prices
James Love, Knowledge Ecology International
Sean Flynn, American University Washington College of Law
Brook Baker, Northeastern University
Rohit Malpani, Oxfam International
Peter Riggs, Forum on Democracy and Trade
Robert Weissman, Essential Action

Sponsored by
Knowledge Ecology International & American University Washington College
of Law Program on Information Justice and Intellectual Property

7pm on Thursday, February 19.
Washington College of Law, located at 4801 Massachusetts Ave., NW
International Student Lounge, Sixth Floor

Registration
http://www.wcl.american.edu/secle/cle_form.cfm

Webcast:
www.wcl.american.edu/pijip/webcast.cfm

Professor John Barton, the former Chair of the UK Commission on
Intellectual Property Rights, and Pfizer CEO Jeff Kindler recently
outlined a proposed global framework on medicine pricing to protect
research and development incentives while promoting greater access to
drugs in low and middle income countries. The proposal calls for trade
agreement measures to restrain developed countries from excessive use of
price controls while promoting price discrimination in middle income
countries so that the richer segments of the population will pay more
than poorer segments. Meanwhile, many global access to medicines
campaigners and developing countries have been advocating for a new
research and development framework that would delink the price of the
product from the incentive to produce new medicines, e.g. through
various proposals for prize funds, direct government funding of research
and development and other means, while promoting full competition for
the supply of needed products.

PIJIP and KEI are pleased to announce that Professor Barton will further
explain and discuss his proposal at the Washington College of Law on
Thursday, February 19. Responders from civil society will comment on the
proposal and offer alternative models for the financing of patent-driven
research for health in middle and low income nations.


--
Mike Palmedo
Research Coordinator
Program on Information Justice and Intellectual Property
American University, Washington College of Law
4910 Massachutsetts Ave., NW Washington, DC 20016
T - 202-274-4442 | F 202-274-0659
mpalmedo@wcl.american.edu